Syngene International Limited announced that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors at its meeting held on January 24, 2017, has approved the appointment of Dr. Vijay Kuchroo as an Additional Director (Non-Executive, Independent) on Board of the company effective from March 1, 2017 to hold office up to the date of next Annual General Meeting, wherein his appointment as an Independent Director will be placed before the members for their approval. Dr. Vijay K Kuchroo, 61 years, is Senior Scientist at Brigham and Women's Hospital and Co-Director of the Center for Infection and Immunity, Brigham Research Institutes, Boston. He is also an Associate Member of the Broad Institute and a participant in a Klarman Cell Observatory project that focuses on T cell differentiation. He is also the Director of the newly formed Evergrande Centre for Immunologic Diseases at Harvard Medical School and Brigham and Women's Hospital. He is also an Independent, Non-Executive Director on the Board of Biocon Limited. He also serves on the scientific advisory Boards and works in advisory capacity to a number of big pharmaceutical companies including Pfizer, Novartis and Glaxo-Smith-Kline (GSK).